Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
Modern problems caused by the high prevalence of smoking, as well as pharmacological approaches that facilitate quitting smoking are discussed in the review. Data on the mechanisms of formation of nicotine addiction, which determine the choice of drug interventions aimed at increasing the probabilit...
Saved in:
Main Author: | S. R. Gilyarevskiy |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2019-03-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison between the role of bupropion and varenicline in the management of nicotine dependence: A prospective comparative study
by: Sphurti Pusukuri, et al.
Published: (2025-01-01) -
SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking
by: O. D. Ostroumova, et al.
Published: (2018-03-01) -
Nicotine dependence and neuropsychotic effects of varenicline
by: T. M. Bukatina, et al.
Published: (2018-03-01) -
Quitline Queensland: the journey to a globally unique smoking cessation service in Australia
by: Joanne Isbel, et al.
Published: (2025-07-01) -
VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY?
by: Yu. V. Lukina, et al.
Published: (2015-09-01)